Where the manufacturer of a non-sterile API either intends or claims that it is
suitable for use in further processing to produce a sterile drug (medicinal) product,
water used in the final isolation and purification steps should be monitored and
controlled for total microbial counts, objectionable organisms, and endotoxins.